
Keywords: T2DM; type 2 diabetes; GLP-1; glucagon-like peptide-1; DPP-IV; dipeptidyl peptidase IV; des-F-sitagliptin; des-fluoro-sitagliptin; PFK; 26-phosphofructo-2-kinase/fructose-2,6-biphosphatase; CF; cytosolic fraction; DNF; nuclear fraction; qPCR; real-time PC